Paul Rubin

Paul leads the clinical development of BIOAGE's pipeline of therapies that target aging. Paul is an experienced pharma and biotech executive with extensive experience in small molecules, biologics and oligonucleotide therapeutics and has advanced dozens of compounds from discovery through approval. He has worked in multiple therapeutic areas where he was intimately involved with discovery, preclinical and clinical development, regulatory and marketing. Prior to joining BIOAGE, Paul was Executive VP Research and Development at miRagen from 2016-2020. He was Senior VP of Research and Development and CMO at XOMA. Ltd from 2011 – 2015, CEO of Resolvyx Pharmaceuticals, Inc. from 2007 to 2009, and President and CEO of Critical Therapeutics, Inc. from 2002 to 2007.